BOULDER, Colorado, July 9, 2019 – Skyland Analytics, a leading provider of cloud-based data analytics and data management solutions for the life science industry, announced today the appointment of Dave Withers to its Board of Directors. Mr. Withers has founded and advised several successful SaaS software companies.
“I’m honored to join Skyland’s Board and I look forward to helping Skyland transform the way life science companies manage, share and extract more value from their product, process and patient data,” said Dave Withers. “I’m excited to collaborate with a company that can leverage extensive experience in the space with fresh technology approaches that address the needs of emerging and global companies and their external partners.”
Mr. Withers brings a 25-year track record of identifying transformative technologies to the Skyland Analytics Board. As an entrepreneur, he was a founder and senior executive in the storage, cloud, and SaaS industries. Most recently, Mr. Withers was the CEO and Co-Founder of Renasar Technologies, an infrastructure software company that was acquired by EMC where he stayed on as VP of Technology for Global Platform Engineering through the acquisition by Dell. Prior to Renasar, Mr. Withers held operating and executive roles at Nebula, Ocarina (acquired by Dell), and Isilon (acquired by EMC), PolyServe (acquired by HP), Access Graphics (acquired by GE), and APC (acquired by Schneider Electric).
“Given the business requirements, compliance obligations and reliance on external partners, no aspect of the pharmaceutical business stands to benefit more from cloud-based data management and analytics than development and manufacturing operations,” said Bob Di Scipio, Skyland’s CEO. “Dave’s extensive experience in cloud SaaS technologies will be drawn upon as we not only solidify our position as the leading innovator for life science process and product data management but go-to-market in industries such as chemical, medicinal cannabis and food and beverage.”
About Skyland Analytics
Skyland Analytics helps biopharma manufacturers streamline drug product and process data management by offering cloud-based software solutions, including Skyland PIMS®, that ensure Part 11-compliant data transparency and integrity throughout the product lifecycle and supply chain.
With deep expertise in manufacturing, IT systems, data analytics, product quality and process intellectual property, Skyland is uniquely positioned to support emerging and global companies seeking to enhance product quality and process analysis and manage data across global manufacturing networks.
For more information visit www.skylandanalytics.net.
Skyland Analytics Media Contact
Senior Director, Marketing